Treatment With Duloxetine for OCD Patients

This study has been withdrawn prior to enrollment.
(Funding was not recieved)
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00399022
First received: November 13, 2006
Last updated: January 28, 2008
Last verified: January 2008

November 13, 2006
January 28, 2008
Not Provided
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00399022 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment With Duloxetine for OCD Patients
Not Provided

Testing the efficacy of the SNRI medication Duloxetine for treating OCD patients who did not respond to SSRI

Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
OCD
Drug: Duloxetine
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
40
Not Provided
Not Provided

Inclusion Criteria:

  • OCD as main diagnosis according to DSM-IV
  • Age 18 to 65
  • Men and women
  • YBOCS score is 18 or more, or 12 or more in case of only obsessions

Exclusion Criteria:

  • Patients treated with Duloxetine, currently or in the past
  • Patients having comorbid schizophrenia or psychotic disorder or bipolar disorder Patients with substance abuse disorder in the last 6 months Patients who were suicidal or did serious suicide attempt in the last year Pregnant or lactating women, or woman of childbearing potential, which is not using adequate contraception Patients with neurologic disturbance or disorder Patients with serious or imbalanced medical condition Patients with allergic response to SSRI or duloxetine Patients who started new treatment (CBT or pharmacology) in less than 3 months
Both
18 Years to 65 Years
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00399022
SHEBA-06-4360-JZ-CTIL
Not Provided
Prof. Joseph Zohar, Chaim Sheba Medical Center
Sheba Medical Center
Not Provided
Principal Investigator: Joseph Zohar, MD Chaim Sheba Medical Center
Sheba Medical Center
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP